Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 8, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | $20.84B | $173.93 | $227.57 | 30.84% | 33.48% | Strong Buy | Strong Buy | 7 | 6 | 10.41% | 28.36% | 30.98% | 17.47% |
| TPR | TAPESTRY INC | $20.22B | $98.81 | $122.43 | 23.90% | 27.21% | Strong Buy | Strong Buy | 14 | 10 | 3.40% | 71.42% | 352.46% | 22.13% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $8.15B | $134.05 | $177.78 | 32.62% | 32.62% | Strong Buy | Strong Buy | 9 | 9 | 5.44% | N/A | 39.11% | 13.63% |
| MOG.A | MOOG INC | $6.33B | $199.93 | $240.00 | 20.04% | 20.04% | Strong Buy | Strong Buy | 1 | 1 | 7.97% | 31.18% | 18.68% | 8.26% |
| SGHC | SUPER GROUP (SGHC) LTD | $5.94B | $11.75 | $18.00 | 53.19% | 56.03% | Strong Buy | Strong Buy | 6 | 3 | 1.91% | 23.81% | N/A | N/A |
| GTES | GATES INDUSTRIAL CORP PLC | $5.56B | $21.53 | $28.14 | 30.72% | 25.41% | Strong Buy | Strong Buy | 7 | 5 | 3.60% | 28.52% | 15.24% | 7.19% |
| CALX | CALIX INC | $4.27B | $64.37 | $77.75 | 20.79% | 20.79% | Strong Buy | Strong Buy | 4 | 4 | 10.39% | N/A | 20.96% | 17.66% |
| DLO | DLOCAL LTD | $3.99B | $13.60 | $16.33 | 20.10% | 39.71% | Strong Buy | Strong Buy | 6 | 1 | 23.14% | 28.75% | 69.35% | 25.44% |
| RSI | RUSH STREET INTERACTIVE INC | $3.80B | $16.55 | $22.00 | 32.93% | 32.93% | Strong Buy | Strong Buy | 6 | 6 | 10.50% | 25.13% | 109.17% | 24.49% |
| TPC | TUTOR PERINI CORP | $3.55B | $67.40 | $82.00 | 21.66% | 21.66% | Strong Buy | Strong Buy | 3 | 3 | 8.63% | N/A | 26.82% | 6.19% |
| MIRM | MIRUM PHARMACEUTICALS INC | $3.40B | $67.72 | $87.11 | 28.63% | 25.76% | Strong Buy | Strong Buy | 9 | 6 | 19.47% | N/A | 33.44% | 11.75% |
| FOLD | AMICUS THERAPEUTICS INC | $2.74B | $8.90 | $38.00 | 326.97% | 326.97% | Strong Buy | Strong Buy | 4 | 4 | 17.19% | N/A | 236.99% | 59.39% |
| EXTR | EXTREME NETWORKS INC | $2.34B | $17.51 | $23.33 | 33.26% | 39.92% | Buy | Strong Buy | 3 | 2 | 7.51% | 176.17% | 281.16% | 16.72% |
| SPNT | SIRIUSPOINT LTD | $2.26B | $19.37 | $27.50 | 41.97% | 54.88% | Strong Buy | Strong Buy | 2 | 1 | 0.31% | 20.42% | 14.02% | 2.49% |
| IHS | IHS HOLDING LTD | $2.15B | $6.41 | $9.85 | 53.67% | 40.41% | Strong Buy | Strong Buy | 5 | 2 | 4.00% | 25.00% | -140.16% | 8.45% |
| ARDT | ARDENT HEALTH INC | $2.07B | $14.46 | $17.80 | 23.10% | 33.13% | Buy | Strong Buy | 7 | 4 | 4.98% | 5.32% | N/A | N/A |
| FIVN | FIVE9 INC | $1.66B | $21.54 | $33.00 | 53.20% | 57.85% | Strong Buy | Strong Buy | 6 | 5 | 8.18% | 201.88% | 39.93% | 16.80% |
| BLBD | BLUE BIRD CORP | $1.60B | $50.54 | $61.67 | 22.02% | 28.61% | Strong Buy | Strong Buy | 3 | 1 | 6.29% | 12.74% | N/A | N/A |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.48B | $7.03 | $19.25 | 173.83% | 190.18% | Strong Buy | Strong Buy | 8 | 5 | 10.18% | N/A | -68.82% | 63.46% |
| CRTO | CRITEO SA | $1.18B | $22.50 | $41.60 | 84.89% | 88.89% | Strong Buy | Strong Buy | 5 | 4 | -9.20% | 18.58% | N/A | N/A |
| NRDS | NERDWALLET INC | $892.66M | $11.98 | $15.33 | 27.99% | 27.99% | Strong Buy | Strong Buy | 3 | 3 | 7.61% | 28.98% | N/A | N/A |
| UDMY | UDEMY INC | $759.70M | $5.19 | $10.20 | 96.53% | 79.83% | Strong Buy | Strong Buy | 5 | 3 | 2.92% | N/A | N/A | N/A |
| TBPH | THERAVANCE BIOPHARMA INC | $748.87M | $14.87 | $25.67 | 72.61% | 78.21% | Strong Buy | Strong Buy | 3 | 2 | 12.70% | -7.15% | 15.00% | 7.92% |
| LYTS | LSI INDUSTRIES INC | $630.08M | $20.65 | $25.00 | 21.07% | 21.07% | Strong Buy | Strong Buy | 1 | 1 | 7.02% | 23.40% | 19.69% | 11.46% |
| BWMN | BOWMAN CONSULTING GROUP LTD | $593.85M | $34.46 | $42.00 | 21.88% | 21.88% | Strong Buy | Strong Buy | 2 | 2 | 13.26% | 362.81% | 9.81% | 4.53% |
| AKBA | AKEBIA THERAPEUTICS INC | $527.90M | $2.01 | $5.50 | 173.63% | 173.63% | Strong Buy | Strong Buy | 2 | 2 | 21.58% | N/A | 403.23% | 31.95% |
| KMDA | KAMADA LTD | $380.68M | $6.62 | $15.00 | 126.59% | 126.59% | Strong Buy | Strong Buy | 1 | 1 | 8.80% | 16.95% | 11.73% | 8.28% |
| EGHT | 8X8 INC | $268.65M | $1.97 | $2.75 | 39.59% | 26.90% | Strong Buy | Strong Buy | 2 | 1 | 0.77% | N/A | 29.30% | 5.49% |
| NATR | NATURES SUNSHINE PRODUCTS INC | $242.14M | $13.73 | $20.50 | 49.31% | 60.23% | Strong Buy | Strong Buy | 2 | 1 | 3.39% | 23.19% | 9.62% | 6.18% |
| INFU | INFUSYSTEM HOLDINGS INC | $209.26M | $10.29 | $14.50 | 40.91% | 36.05% | Strong Buy | Strong Buy | 2 | 1 | 6.14% | 20.83% | 17.54% | 9.84% |
| CXDO | CREXENDO INC | $207.43M | $6.75 | $9.13 | 35.19% | 62.96% | Strong Buy | Strong Buy | 4 | 1 | 8.14% | 57.13% | 22.48% | 18.16% |
| ELMD | ELECTROMED INC | $203.22M | $24.34 | $35.50 | 45.85% | 43.80% | Strong Buy | Strong Buy | 2 | 1 | 10.20% | 11.15% | 21.68% | 17.41% |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.